Sixty-one patients underwent thrombophilia testing (including factor V Leiden mutation, prothrombin gene mutation, antithrombin levels, protein C and S, lupus anticoagulant, anti-cardiolipin and β2-glycoprotein antibodies), with six patients identified as factor V Leiden heterozygous. Here, F2 is linked to Rare hereditary thrombophilia.